Home/Filings/4/0001213900-21-046738
4//SEC Filing

Quake Stephen 4

Accession 0001213900-21-046738

CIK 0001837412other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 8:10 PM ET

Size

15.5 KB

Accession

0001213900-21-046738

Insider Transaction Report

Form 4
Period: 2021-09-01
Transactions
  • Award

    Warrants to purchase Class A Common Stock (right to buy)

    2021-09-01+166,666166,666 total
    Exercise: $11.50From: 2021-10-01Exp: 2026-09-01Class A Common Stock (166,666 underlying)
  • Other

    Class A Common Stock

    2021-09-01+25,00025,000 total
  • Exercise/Conversion

    Class B Common Stock

    2021-09-0125,0000 total
    Class A Common Stock (25,000 underlying)
  • Award

    Class A Common Stock

    2021-09-01$10.00/sh+150,000$1,500,000325,000 total(indirect: By Foundation)
  • Award

    Class A Common Stock

    2021-09-01$10.00/sh+100,000$1,000,000425,000 total(indirect: By Trust)
  • Award

    Class A Common Stock

    2021-09-01$10.00/sh+150,000$1,500,000175,000 total(indirect: By Trust)
Footnotes (3)
  • [F1]In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as CM Life Sciences II Inc. or "CMLS II") and SomaLogic, Inc. ("SomaLogic"), among other things, each share of CMLS II's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis.
  • [F2]In connection with the Closing of the Business Combination, 400,000 shares of Class A Common stock were issued and owned directly by Quake 2018 Charitable Remainder Unitrust, The Eleftheria Foundation and DeltaXDeltaP Hbar Trust, respectively (the "Quake Entities"). Mr. Quake has voting and investment discretion with respect to the Class A Common Stock held of record by the Quake Entities. Mr. Quake disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  • [F3]Following the completion of the Business Combination, warrants to purchase Class A Common Stock become exercisable on October 1, 2021, the date that is 30 days after the closing of the Business Combination.

Documents

1 file

Issuer

SomaLogic, Inc.

CIK 0001837412

Entity typeother

Related Parties

1
  • filerCIK 0001685889

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 8:10 PM ET
Size
15.5 KB